Effect of Continuous Subcutaneous Administration of a Low Dose of G-CSF on Stem Cell Mobilization in Healthy Donors: A Feasibility Study
- 1 June 2002
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 75 (5) , 489-492
Abstract
We investigated the effects of low-dose granulocyte colony-stimulating factor (G-CSF) on the mobilization of stem cells in 6 healthy subjects. When G-CSF was administered by continuous subcutaneous infusion at a rate of 72 μg/day for 5 days, the numbers of white blood cells and granulocytes rapidly increased to maximal levels. CD34+ cells were mobilized to the peripheral blood in 3 days, and the maximal level was reached 4 or 5 days after the start of treatment. We attempted to determine whether the levels of mobilized stem cells that we could obtain using this method would be sufficient for peripheral blood stem cell transplantation. Two of the 6 subjects complained of mild bone pain 4 or 5 days after the start of treatment, but the pain did not affect their daily activities. Only 1 abnormal result (for serum alkaline phosphatase) was found in the laboratory data. The present preliminary results have provided us with a framework for a prospective study comparing low-dose continuous infusion with conventional mobilization procedures.Int J Hematol. 2002;75:489–492.Keywords
This publication has 13 references indexed in Scilit:
- A randomised study of allogeneic transplantation with stem cells from blood or bone marrowBone Marrow Transplantation, 2000
- Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF.2000
- [Effect of lenograstim (glycosylated recombinant human granulocyte-colony stimulating factor) on peripheral blood stem cell mobilization in healthy volunteers].2000
- Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factorBone Marrow Transplantation, 2000
- Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donorThe Lancet, 1999
- [Mobilization and collection of peripheral blood stem cells].1996
- Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.1996
- Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cellsTransfusion, 1996
- Effect of continuous subcutaneous administration of a small dose of granulocyte colony stimulating factor (G-CSF) by the use of a portable infusion pump in patients with non-Hodgkin's lymphoma receiving chemotherapy.1995
- Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.1992